Table 3.
Instance of modification | Implication |
---|---|
• Controlled release and sustained release formulations | • Erratic/delayed absorption • Toxic/sub-therapeutic doses • Increased risk of side effects |
• Enteric-coated formulations | • Altered absorption • Increased side effects such as gastric irritation • Instability and inactivity of medication |
• Sugar-coated formulations | • Altered taste |
• Film-coated formulations | • Decreased adherence |
• Light-sensitive formulations | • Physicochemical instability |
• Humidity-sensitive formulations | |
• Hormonal or cytotoxic medications | • Occupational exposure of health care professionals • Inhalation of drug particles • Dermal contact • Risk of allergies, infertility, congenital malformations, abortion |
• Process of dosage form modification | • Powder loss/spillage • Inaccurate dosing • Cross-contamination • Physicochemical incompatibility of mixed medications |